Stock Analysis on Net

Balance Sheet: Liabilities and Stockholders’ Equity
Quarterly Data

The balance sheet provides creditors, investors, and analysts with information on company resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company assets as well as an indication of cash flows that may come from receivables and inventories.

Liabilities represents obligations of a company arising from past events, the settlement of which is expected to result in an outflow of economic benefits from the entity.

Humana Inc., consolidated balance sheet: liabilities and stockholders’ equity (quarterly data)

US$ in millions

Microsoft Excel
Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Benefits payable 11,729 10,241 10,196 10,304 10,018 9,264 9,237 9,650 9,378 8,289 8,758 8,485 8,651 8,143 8,208 7,980 7,090 6,004 6,220 5,842 6,024
Trade accounts payable and accrued expenses 6,504 6,569 7,600 8,118 7,431 5,238 6,766 5,787 5,859 4,509 4,957 4,898 4,777 4,013 4,472 6,175 5,399 3,754 3,640 3,832 3,719
Book overdraft 333 353 246 457 406 298 237 391 317 326 240 236 343 320 214 310 169 225 273 204 154
Unearned revenues 301 266 7,536 7,378 7,220 286 6,012 264 288 254 277 323 325 318 287 266 274 247 274 312 312
Short-term debt 822 1,443 2,245 2,022 1,867 2,092 2,799 1,541 1,690 1,953 795 1,109 1,204 600 1,724 1,724 1,898 699 699 1,349 1,718
Current liabilities held-for-sale 206
Current liabilities 19,689 18,872 27,823 28,279 26,942 17,178 25,051 17,839 17,532 15,331 15,027 15,051 15,300 13,394 14,905 16,455 14,830 10,929 11,106 11,539 11,927
Long-term debt 12,390 10,213 9,483 9,722 9,743 9,034 7,798 11,290 11,285 10,541 11,466 6,063 6,062 6,060 6,059 6,058 6,057 4,967 5,365 4,377 4,376
Other long-term liabilities 1,826 1,662 1,595 1,563 1,457 1,473 1,599 1,907 2,149 2,383 2,545 2,113 1,863 1,787 1,745 1,526 1,391 1,141 1,108 1,125 1,205
Long-term liabilities held-for-sale 274
Long-term liabilities 14,216 11,875 11,078 11,285 11,200 10,507 9,397 13,471 13,434 12,924 14,011 8,176 7,925 7,847 7,804 7,584 7,448 6,108 6,473 5,502 5,581
Total liabilities 33,905 30,747 38,901 39,564 38,142 27,685 34,448 31,310 30,966 28,255 29,038 23,227 23,225 21,241 22,709 24,039 22,278 17,037 17,579 17,041 17,508
Preferred stock, $1 par; none issued
Common stock, $0.16 2/3 par 33 33 33 33 33 33 33 33 33 33 33 33 33 33 33 33 33 33 33 33 33
Capital in excess of par value 3,369 3,346 3,362 3,313 3,262 3,246 3,234 3,153 3,103 3,082 3,064 3,018 2,712 2,705 2,940 2,898 2,857 2,820 2,608 2,763 2,722
Retained earnings 28,173 27,540 28,191 27,468 26,619 25,492 25,606 24,511 23,915 23,086 23,191 21,751 21,252 20,517 20,872 19,616 17,871 17,483 17,045 16,429 15,563
Accumulated other comprehensive income (loss) (1,086) (999) (1,503) (1,226) (1,113) (1,304) (1,467) (1,051) (572) 42 145 216 108 391 370 317 48 156 177 112 (10)
Treasury stock, at cost (14,359) (13,658) (13,134) (12,754) (12,224) (12,156) (11,152) (11,156) (11,160) (10,163) (10,173) (10,175) (9,915) (9,918) (8,447) (8,448) (8,454) (8,455) (8,262) (7,465) (7,467)
Stockholders’ equity 16,130 16,262 16,949 16,834 16,577 15,311 16,254 15,490 15,319 16,080 16,260 14,843 14,190 13,728 15,768 14,416 12,355 12,037 11,601 11,872 10,841
Noncontrolling interests 56 56 55 57 57 59 63 20 23 23 22
Total equity 16,186 16,318 17,004 16,891 16,634 15,370 16,317 15,510 15,342 16,103 16,282 14,843 14,190 13,728 15,768 14,416 12,355 12,037 11,601 11,872 10,841
Total liabilities and equity 50,091 47,065 55,905 56,455 54,776 43,055 50,765 46,820 46,308 44,358 45,320 38,070 37,415 34,969 38,477 38,455 34,633 29,074 29,180 28,913 28,349

Based on: 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31).

Balance sheet item Description The company
Current liabilities Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. Humana Inc. current liabilities decreased from Q3 2023 to Q4 2023 but then slightly increased from Q4 2023 to Q1 2024.
Long-term liabilities Amount of obligation due after one year or beyond the normal operating cycle, if longer. Humana Inc. long-term liabilities increased from Q3 2023 to Q4 2023 and from Q4 2023 to Q1 2024.
Total liabilities Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future. Humana Inc. total liabilities decreased from Q3 2023 to Q4 2023 but then slightly increased from Q4 2023 to Q1 2024.
Stockholders’ equity Total of all stockholders’ equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity stockholders’ equity attributable to the parent excludes the amount of stockholders’ equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity. Humana Inc. stockholders’ equity decreased from Q3 2023 to Q4 2023 and from Q4 2023 to Q1 2024.